methyl (15R,18R,19R,20R)-18-hydroxy-11,12,14,15,16,17,18,19,20,21-decahydroyohimban-19-carboxylate

Details

Top
Internal ID a9e8638d-bf7b-43c8-9f4e-39bed17d6661
Taxonomy Alkaloids and derivatives > Yohimbine alkaloids
IUPAC Name methyl (15R,18R,19R,20R)-18-hydroxy-11,12,14,15,16,17,18,19,20,21-decahydroyohimban-19-carboxylate
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C21H24N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,18-19,24H,6-11H2,1H3/t12-,15+,18+,19+/m0/s1
InChI Key ABXHGHKISIEEEJ-GGCQVYRISA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C21H24N2O3
Molecular Weight 352.40 g/mol
Exact Mass 352.17869263 g/mol
Topological Polar Surface Area (TPSA) 62.10 Ų
XlogP 2.10
Atomic LogP (AlogP) 0.97
H-Bond Acceptor 5
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of methyl (15R,18R,19R,20R)-18-hydroxy-11,12,14,15,16,17,18,19,20,21-decahydroyohimban-19-carboxylate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9845 98.45%
Caco-2 + 0.8905 89.05%
Blood Brain Barrier + 0.6500 65.00%
Human oral bioavailability + 0.5714 57.14%
Subcellular localzation Mitochondria 0.8421 84.21%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9209 92.09%
OATP1B3 inhibitior + 0.9396 93.96%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.6389 63.89%
BSEP inhibitior + 0.8785 87.85%
P-glycoprotein inhibitior - 0.5768 57.68%
P-glycoprotein substrate + 0.7121 71.21%
CYP3A4 substrate + 0.6910 69.10%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.6649 66.49%
CYP3A4 inhibition - 0.8622 86.22%
CYP2C9 inhibition - 0.8524 85.24%
CYP2C19 inhibition - 0.8274 82.74%
CYP2D6 inhibition + 0.6848 68.48%
CYP1A2 inhibition - 0.5687 56.87%
CYP2C8 inhibition - 0.5917 59.17%
CYP inhibitory promiscuity - 0.8708 87.08%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9400 94.00%
Carcinogenicity (trinary) Non-required 0.5703 57.03%
Eye corrosion - 0.9820 98.20%
Eye irritation - 0.9845 98.45%
Skin irritation - 0.7417 74.17%
Skin corrosion - 0.9214 92.14%
Ames mutagenesis - 0.6778 67.78%
Human Ether-a-go-go-Related Gene inhibition + 0.8266 82.66%
Micronuclear + 0.5700 57.00%
Hepatotoxicity - 0.5500 55.00%
skin sensitisation - 0.8346 83.46%
Respiratory toxicity + 0.9111 91.11%
Reproductive toxicity + 0.9444 94.44%
Mitochondrial toxicity + 0.9625 96.25%
Nephrotoxicity + 0.5525 55.25%
Acute Oral Toxicity (c) III 0.5510 55.10%
Estrogen receptor binding + 0.7850 78.50%
Androgen receptor binding + 0.7143 71.43%
Thyroid receptor binding - 0.5108 51.08%
Glucocorticoid receptor binding - 0.5919 59.19%
Aromatase binding - 0.7265 72.65%
PPAR gamma - 0.7012 70.12%
Honey bee toxicity - 0.8897 88.97%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity + 0.6649 66.49%
Fish aquatic toxicity + 0.7915 79.15%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.48% 96.09%
CHEMBL4040 P28482 MAP kinase ERK2 97.23% 83.82%
CHEMBL2581 P07339 Cathepsin D 96.40% 98.95%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 94.13% 85.14%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.48% 95.56%
CHEMBL1293249 Q13887 Kruppel-like factor 5 90.05% 86.33%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 89.65% 91.11%
CHEMBL5028 O14672 ADAM10 87.05% 97.50%
CHEMBL301 P24941 Cyclin-dependent kinase 2 85.48% 91.23%
CHEMBL3137262 O60341 LSD1/CoREST complex 81.44% 97.09%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Aspidosperma oblongum

Cross-Links

Top
PubChem 163188953
LOTUS LTS0039480
wikiData Q104908912